Molecular genetic tests for <i>JAK2</i> V617F, Exon12_ <i>JAK2</i> and <i>MPL</i> W515K/L are highly informative in the evaluation of patients suspected to have BCR-ABL1-negative myeloproliferative neoplasmsMarcos Tadeu dos Santos, Edgar Gil Rizzatti, Miguel Mitne‐Neto et al.|Journal of Clinical Pathology|2013Cited by 7